---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-21-053525"
form_type: "8-K"
ticker: "OPRX"
cik: "0001448431"
company_name: "OptimizeRx Corp"
filed_at: "2021-10-19T23:59:59+00:00"
generated_at: "2026-06-28T19:56:57.075535+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# OptimizeRx CEO William Febbo gets $12.5M PRSU grant, base salary to $450k

## Summary
- Base salary increased to $450,000 upon signing; annual target bonus raised to 100% of base salary.
- Granted $12.5M performance-based RSUs with three stock price milestones: 50%, 100%, 150% above base price of $65.91.
- PRSUs earned over five years; each milestone requires stock price >= target for 30 consecutive trading days; vesting on first anniversary of milestone date.
- RSU grant intended as CEO's only equity award for next five years, replacing annual grants; compensation committee may reconsider.
- Milestones set for compensation purposes only; not management projection.

## SEC filing metadata
- accession: 0001213900-21-053525
- form_type: 8-K
- ticker: OPRX
- cik: 0001448431
- company_name: OptimizeRx Corp
- filed_at: 2021-10-19T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1448431/000121390021053525/0001213900-21-053525-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1448431/000121390021053525/ea149083-8k_optimizerx.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-21-053525
- JSON: https://secwatch.observer/filing/0001213900-21-053525.json
- Plain text: https://secwatch.observer/filing/0001213900-21-053525.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.